These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 7299649)

  • 41. Inhibition of macromolecular synthesis in P388 mouse leukemia ascites cells by bouvardin (NSC 259968).
    Chitnis M; Menon R; Adwankar M; Satyamoorthy K
    Tumori; 1985 Jun; 71(3):261-6. PubMed ID: 4024280
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antitumor agents, 74. Bruceanol-A and -B, two new antileukemic quassinoids from Brucea antidysenterica.
    Okano M; Fukamiya N; Aratani T; Juichi M; Lee KH
    J Nat Prod; 1985; 48(6):972-5. PubMed ID: 3841557
    [No Abstract]   [Full Text] [Related]  

  • 43. Antitumor agents. 44. Bis(helenalinyl) esters and related derivatives as novel potent antileukemic agents.
    Lee KH; Ibuka T; Sims D; Muraoka O; Kiyokawa H; Hall IH; Kim HL
    J Med Chem; 1981 Aug; 24(8):924-7. PubMed ID: 7328595
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Radioimmunoassay for the detection and quantitation of bruceantin.
    Fong KL; Ho DH; Carter CJ; Brown NS; Benjamin RS; Freireich EJ; Bodey GP
    Anal Biochem; 1980 Jul; 105(2):281-6. PubMed ID: 7457834
    [No Abstract]   [Full Text] [Related]  

  • 45. Antitumor agents. 21. A proposed mechanism for inhibition of cancer growth by tenulin and helenalin and related cyclopentenones.
    Hall IH; Lee KH; Mar EC; Starnes CO; Waddell TG
    J Med Chem; 1977 Mar; 20(3):333-7. PubMed ID: 845864
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of bouvardin (NSC 259968) on the growth characteristics an nucleic acids and protein syntheses profiles of P388 leukemia cells.
    Chitnis MP; Alate AD; Menon RS
    Chemotherapy; 1981; 27(2):126-30. PubMed ID: 7471902
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cytotoxic quassinoids from Cedronia granatensis.
    Tischler M; Cardellina JH; Boyd MR; Cragg GM
    J Nat Prod; 1992 May; 55(5):667-71. PubMed ID: 1517739
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Quassinoid bitter principles. II.
    Polonsky J
    Fortschr Chem Org Naturst; 1985; 47():221-64. PubMed ID: 3896993
    [No Abstract]   [Full Text] [Related]  

  • 49. A Phase II study of Bruceantin (NSC-165, 563) in advanced malignant melanoma.
    Arseneau JC; Wolter JM; Kuperminc M; Ruckdeschel JC
    Invest New Drugs; 1983; 1(3):239-42. PubMed ID: 6678872
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Plant antitumor agents. XVI. 6alpha-Senecioyloxy-chaparrinone, a new antileukemic quassinoid from Simaba multiflora.
    Wani MC; Taylor HL; Thompson JB; Wall ME
    Lloydia; 1978; 41(6):578-83. PubMed ID: 732540
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Use of microdilution to assess in vitro antiamoebic activities of Brucea javanica fruits, Simarouba amara stem, and a number of quassinoids.
    Wright CW; O'Neill MJ; Phillipson JD; Warhurst DC
    Antimicrob Agents Chemother; 1988 Nov; 32(11):1725-9. PubMed ID: 2908094
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Role of thiol agents in protecting against the toxicity of helenalin in tumor-bearing mice.
    Hall IH; Grippo AA; Holbrook DJ; Roberts G; Lin HC; Kim HL; Lee KH
    Planta Med; 1989 Dec; 55(6):513-7. PubMed ID: 2616670
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Inhibitory effects of quassinoid derivatives on Epstein-Barr virus early antigen activation.
    Rahman S; Fukamiya N; Ohno N; Tokuda H; Nishino H; Tagahara K; Lee KH; Okano M
    Chem Pharm Bull (Tokyo); 1997 Apr; 45(4):675-7. PubMed ID: 9145503
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The effects of genkwadaphnin and gnidilatidin on the growth of P-388, L-1210 leukemia and KB carcinoma cells in vitro.
    Hall IH; Liou YF; Oswald CB; Lee KH
    Eur J Cancer Clin Oncol; 1986 Jan; 22(1):45-52. PubMed ID: 3754212
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Antimalarial activity of quassinoids against chloroquine-resistant Plasmodium falciparum in vitro.
    Trager W; Polonsky J
    Am J Trop Med Hyg; 1981 May; 30(3):531-7. PubMed ID: 7020445
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Antitumor agents 32. Synthesis and antitumor activity of cyclopentenone derivatives related to helenalin.
    Lee KH; Mar EC; Okamoto M; Hall IH
    J Med Chem; 1978 Aug; 21(8):819-22. PubMed ID: 691008
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Phase II trial of bruceantin in metastatic breast carcinoma.
    Wiseman CL; Yap HY; Bedikian AY; Bodey GP; Blumenschein GR
    Am J Clin Oncol; 1982 Aug; 5(4):389-91. PubMed ID: 7113961
    [TBL] [Abstract][Full Text] [Related]  

  • 58. 1H- and 13C-NMR spectroscopic studies of selected quassinoids.
    Hamburger MO; Cordell GA
    Planta Med; 1988 Aug; 54(4):352-5. PubMed ID: 3222379
    [No Abstract]   [Full Text] [Related]  

  • 59. [Antitumor activity of trewiasine in vitro and in vivo].
    Yang JL; Shen ZM; Lu LJ; Han JX; Xu CH
    Zhongguo Yao Li Xue Bao; 1988 Nov; 9(6):508-11. PubMed ID: 3256213
    [No Abstract]   [Full Text] [Related]  

  • 60. Antitumor activity of Rabdosia and Teucrium diterpenoids against P 388 lymphocytic leukemia in mice.
    Nagao Y; Ito N; Kohno T; Kuroda H; Fujita E
    Chem Pharm Bull (Tokyo); 1982 Feb; 30(2):727-9. PubMed ID: 7094154
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.